RESELIGO
3,6MG IMP ISP 1
| SÚKL code | 0246044 |
|---|---|
| Name of the product | RESELIGO |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | RESELIGO |
| Supplement | 3,6MG IMP ISP 1 |
| Strenght | 3,6MG |
| Pharmaceutical form | Implant in pre-filled syringe |
| Package | 1 |
| Route | Subcutaneous use |
| Language of the pack | Czech |
| Wrap type | Pre-filled syringe |
| Legal status | na lékařský předpis |
| Active substance | GOSERELIN ACETATE (GOSERELINI ACETAS) |
| ATC group | L02AE03 |
| ATC group name | GOSERELIN |
| Doping | Hormony, růstové faktory a příbuzné látky (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | 56/ 107/16-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 31. 08. 2022 |
| MA Holder | Alvogen Pharma Trading Europe EOOD, Sofia |
| MA Holder country | BULHARSKO |
| Actual MA holder | Zentiva, k.s., Praha |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz